Xi'an QinKai Biotech Co., Ltd. was founded in 2005. For past years, we have always focused on R&D, production and sales of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Now, we have more than 700 m² of synthesis laboratories equipped with a variety of R&D equipments and analysis laboratories equipped with chromatograph, preparative chromatograph and other basic test equipments. Good cooperative relationships with local universities provide us access to their large equipments, such as nuclear magnetic resonance spectrometer, X-ray diffraction instrument, etc. After years of well operation, our company established a 2200 m² of new base for R&D, production and office. The new base is located in Enterprise Accelerator of Xi'an Hi-Tech Industries Development Zone, Caotang, Huyi District, Xi'an City and will be put into use in July, 2018. From then on, our R&D level will be further improved, and our production capacity will be further expanded.

  We could provide more than 100 products which fall into six main categories. The most important products are vitamin D derivatives, including APIs, intermediates and impurities. These vitamin D derivatives are Eldecalcitol, Calcipotriol, Calcitriol, Paricalcitol, Maxacalcitol, Calcifediol, Doxercalciferol and Alfacalcidol. Through many years of R&D and production about this series of products, we have accumulated abundant practical experiences, which give us superior advantages of technology and production.

  Xi'an QinKai Biotech Co., Ltd. wish to establish long-term cooperative relations with customers all over the world. We insist on the principle of “Quality First, Customers Supreme” and will wholeheartedly provide the best products and the related technical services to all of our customers.